Evaluation of dimethoate toxicity on fertilization and on embryonic development of Paracentrotus lividus (Lamarck, 1816).
Elena Maria ScalisiRoberta PecoraroAntonio SalvaggioAurora CorsaroGiuseppina MessinaSara IgnotoBianca Maria LombardoMaria Violetta BrundoPublished in: Toxicology research (2020)
Organophosphates are a large class of chemicals with anticholinesterase action insecticides. Dimethoate belongs to the class of organophosphates and it is used for agriculture purpose. Its main toxicological role in animals and humans is the inhibition of the activity of acetylcholinesterase. Although it is not considered genotoxic, carcinogenic and teratogen, there is evidence of increased pup mortality in developmental neurotoxicity studies. Since there is scant published literature about developmental toxicity, we investigated the adverse effects of dimethoate on fertilization and embryonic development in sea urchin (Paracentrotus lividus), a model organism widely used to assess the toxicity of contaminants on environmental matrices; so pesticide residues can be released into the environment, and could affect the health of organisms, including humans. Different solution of dimethoate (4 × 10-3, 4 × 10-4, 4 × 10-5, 4 × 10-6 and 4 × 10-7 g/10 ml) have been tested on spermatozoa of P. lividus to evaluate the fertilizing ability of them when we added egg cells untreated. We demonstrated that dimethoate does not interfere with fertilizing ability of spermatozoa but egg cells fertilized by treated spermatozoa showed alterations in the segmentation planes as asymmetric and/or asynchronous cell divisions.
Keyphrases
- induced apoptosis
- oxidative stress
- cell cycle arrest
- healthcare
- systematic review
- mental health
- public health
- risk assessment
- cell death
- oxide nanoparticles
- cardiovascular events
- randomized controlled trial
- endoplasmic reticulum stress
- single cell
- stem cells
- risk factors
- cell therapy
- mesenchymal stem cells
- human health
- drinking water
- convolutional neural network
- coronary artery disease
- newly diagnosed
- meta analyses
- adverse drug